< Back to previous page
Researcher
Johan Neyts
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Faculty of Medicine (Faculty)
Member
From1 Oct 2000 → 30 Sep 2002 - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Infrastructure
1 - 1 of 1
Projects
31 - 40 of 82
- Developing effective strategies to control or treat infections with hepatitis E virusFrom4 Nov 2019 → 4 Nov 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Optimize viral replication in primary human airway epithelial (HAE) cells for use in antiviral research to combat respiratory viral infectionsFrom22 Sep 2019 → 22 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Moral-oids: An Ethical Exploration of Organoid Models in Biomedical ResearchFrom1 Sep 2019 → 29 Aug 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Intestinal organoids as models for the development of antivirals against human norovirus and rotavirus.From30 Aug 2019 → 19 Jun 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Evaluation of a novel vaccine delivery and expression platform-Plasmid Launched Live Attenuated Viral Vaccine (PLLAV)From1 Mar 2019 → 31 Dec 2022Funding: Foreign private sponsor - undefined
- Organoids for Virus Research - An innovative training-ETN programmeFrom1 Jan 2019 → 31 Dec 2022Funding: H2020-EU.1.3.- EXCELLEN SCIENCE - Marie Skłodowska-Curie actions
- Recent research data predict an increased risk for virus transmission upon Japanese encephalitis virus (JEV) introduction in pigs.From1 Jan 2019 → 30 Jun 2021Funding: Research Environment and Health
- The role of the mosquito vector in arbovirus drug resistance: how to avoid a 'malaria scenario'?From1 Oct 2018 → 30 Sep 2020Funding: BOF - Concerted Research Project from 1994
- Development and mechanism of action of novel inhibitors of rabies virus replication.From17 Sep 2018 → 17 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Classic and new strategies to fight arboviruses: effect of antiviral drugs and skin bacteria on virus infectivityFrom27 Aug 2018 → 4 Oct 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 621
- Mechanism of action of phthalazinone derivatives against rabies virus.(2024)
Authors: Dirk Jochmans, Johan Neyts
Pages: 105838 - Design, synthesis, and molecular modeling studies of novel 2-quinolone-1,2,3-triazole-α-aminophosphonates hybrids as dual antiviral and antibacterial agents.(2024)
Authors: Johan Neyts, Dirk Jochmans, Steven De Jonghe
Pages: 116235 - Beware of drug resistance: Let's not lose tecovirimat against mpox.(2024)
Authors: Johan Neyts, Laurens Liesenborghs
Pages: 276 - 278 - Molnupiravir inhibits human norovirus and rotavirus replication in 3D human intestinal enteroids.(2024)
Authors: Jana Van Dycke, Johan Neyts, Jelle Matthijnssens, Joana Duarte Da Rocha Pereira
Pages: 105839 - Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study.(2024)
Authors: Simon Feys, Sam Vanmassenhove, Bram Boeckx, Seppe Cambier, Yves Debaveye, Greet Hermans, Katrien Lagrou, Johan Neyts, Marijke Peetermans, Joana Duarte Da Rocha Pereira, et al.
Pages: e247 - e260 - Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B Inhibitor(2024)
Authors: Suzanne Kaptein, Johan Neyts
Pages: 4063 - 4082 - Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted(2024)
Authors: Dirk Jochmans, Rana Abdelnabi, Birgit Weynand, Johan Neyts
- Studies of the human-to-human spread of respiratory pathogens.(2024)
Authors: Emmanuel Andre, Johan Neyts
- Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection(2024)
Authors: Rana Abdelnabi, Johan Neyts
- Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of Chikungunya virus(2024)
Authors: Rana Abdelnabi, Johan Neyts, Leen Delang
Patents
1 - 10 of 10
- Corona virus binders (Inventor)
- Lassavirus vaccines (Inventor)
- Chimeric filovirus vaccines (Inventor)
- Chimeric zika-japanese encephalitis virus (Inventor)
- Chimeric yellow fever zika virus strain (Inventor)
- Viral replication inhibitors (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Coronavirus vaccines (Inventor)
- Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity (Inventor)
- Treatment and prevention of dengue disease (Inventor)